As of 2025-12-22, the EV/EBITDA ratio of Accelerate Diagnostics Inc (AXDX) is -1.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AXDX's latest enterprise value is 48.66 mil USD. AXDX's TTM EBITDA according to its financial statements is -32.50 mil USD. Dividing these 2 quantities gives us the above AXDX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 20.5x | 18.8x |
| Forward P/E multiples | 19.7x - 23.8x | 21.7x |
| Fair Price | (83.78) - (86.78) | (85.89) |
| Upside | -246508.8% - -255330.5% | -252718.8% |
| Date | EV/EBITDA |